Key Insights
The Brazil continuous glucose monitoring (CGM) market is experiencing robust growth, projected to reach $270.97 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 13.30% from 2025 to 2033. This expansion is fueled by several key factors. Rising prevalence of diabetes, particularly type 1 and type 2, within the Brazilian population is a primary driver. Increased awareness of the benefits of CGM in managing diabetes, including improved glycemic control and reduced risk of complications, is also significantly contributing to market growth. Furthermore, technological advancements leading to smaller, more accurate, and user-friendly CGM devices are boosting adoption rates. Government initiatives promoting diabetes management and healthcare access are playing a supporting role. The market is segmented by components (sensors and durables) reflecting the technological complexity and recurring revenue streams associated with CGM systems. Key players like Abbott Diabetes Care, Dexcom Inc., Medtronic PLC, and Ascensia Diabetes Care are competing to capture market share, driving innovation and competition. The market's historical period (2019-2024) likely witnessed a period of gradual growth, laying the foundation for the accelerated expansion predicted in the forecast period (2025-2033).
The competitive landscape involves both established multinational corporations and emerging players focusing on providing innovative solutions and improving access to CGM technology. The focus on durable components (CGM devices themselves) indicates a shift towards long-term monitoring solutions, rather than solely relying on disposable sensors. Future growth will likely depend on affordability and accessibility, particularly in underserved populations. Efforts to integrate CGM data with other diabetes management tools and telehealth platforms will likely shape the market's future trajectory. Further research and development efforts focusing on improved sensor accuracy, longer wear times, and reduced costs will be crucial for continued market expansion in Brazil. The substantial growth potential underscores the need for effective strategies to address diabetes management challenges in the country effectively.

Brazil Continuous Glucose Monitoring (CGM) Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Brazil Continuous Glucose Monitoring (CGM) market, encompassing market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period covers 2019-2033, with 2025 as the base and estimated year. The report offers invaluable insights for industry professionals, investors, and stakeholders seeking to understand and capitalize on opportunities within this rapidly evolving market. The total market size is predicted to reach xx Million units by 2033.
Brazil Continuous Glucose Monitoring Market Market Dynamics & Structure
The Brazilian CGM market is characterized by a moderately concentrated landscape, with key players like Abbott Diabetes Care, Dexcom Inc., and Medtronic PLC holding significant market share. However, the presence of smaller players and emerging companies creates a dynamic competitive environment. Technological innovation, driven by advancements in sensor technology and data analytics, is a major growth driver. The regulatory framework, while evolving, plays a crucial role in market access and product approval. The market is also influenced by the availability of competitive substitute therapies and the demographics of the diabetic population. Mergers and acquisitions (M&A) activity has been relatively moderate in recent years, with xx M&A deals recorded between 2019 and 2024.
- Market Concentration: Moderately concentrated, with top 3 players holding approximately xx% market share in 2025.
- Technological Innovation: Miniaturization, improved accuracy, and wireless connectivity are key drivers.
- Regulatory Framework: ANVISA's regulations influence market access and product approvals, posing both opportunities and challenges.
- Competitive Substitutes: Traditional blood glucose monitoring remains a significant competitor.
- End-User Demographics: The increasing prevalence of diabetes fuels market growth; the aging population further contributes.
- M&A Trends: Consolidation is expected to continue, with strategic partnerships and acquisitions shaping the competitive landscape.
Brazil Continuous Glucose Monitoring Market Growth Trends & Insights
The Brazilian CGM market experienced significant growth during the historical period (2019-2024), with a CAGR of xx%. This growth is primarily attributed to increasing diabetes prevalence, rising healthcare expenditure, and growing awareness about the benefits of continuous glucose monitoring. Technological advancements, such as the introduction of smaller, more accurate sensors, and improved user interfaces, have also driven adoption rates. Consumer behavior is shifting towards more convenient and user-friendly devices, pushing demand for sophisticated, connected CGMs. Market penetration is expected to increase significantly in the forecast period (2025-2033), reaching xx% by 2033. The market is anticipated to maintain a healthy CAGR of xx% during this period, driven by continued technological innovation and increased government initiatives to support diabetes management.

Dominant Regions, Countries, or Segments in Brazil Continuous Glucose Monitoring Market
The South-East region of Brazil dominates the CGM market, driven by higher healthcare infrastructure, greater physician adoption, and a larger diabetic population. Within the component segment, sensors represent the largest share of the market due to their consumable nature and the need for regular replacement. The durable segment, including receivers and transmitters, displays moderate growth due to longer lifecycles.
- Key Drivers in South-East Brazil: Advanced healthcare infrastructure, higher concentration of specialists, and greater patient awareness.
- Sensor Segment Dominance: High demand for disposable sensors, requiring frequent replacements.
- Durable Segment Growth: Driven by technological advancements leading to improved performance and longer lifespans.
Brazil Continuous Glucose Monitoring Market Product Landscape
The Brazilian CGM market offers a range of products, including flash glucose monitoring systems and continuous glucose monitoring systems with varying features like integrated alarms, data sharing capabilities, and mobile app integration. These systems prioritize user-friendliness and accuracy, offering improved diabetes management compared to traditional methods. Recent innovations focus on smaller, less invasive sensors, enhanced data analysis capabilities, and seamless integration with other diabetes management tools.
Key Drivers, Barriers & Challenges in Brazil Continuous Glucose Monitoring Market
Key Drivers:
- Increasing prevalence of diabetes in Brazil.
- Growing awareness of the benefits of CGM among patients and healthcare professionals.
- Technological advancements leading to improved accuracy, smaller sensor size, and better user experience.
- Government initiatives supporting diabetes management and improved healthcare access.
Challenges:
- High cost of CGM devices, limiting accessibility for a significant portion of the population.
- Limited reimbursement coverage by insurance providers.
- Potential supply chain disruptions due to global economic factors.
- Ongoing challenges in integrating CGM data with electronic health records.
Emerging Opportunities in Brazil Continuous Glucose Monitoring Market
The market presents opportunities in expanding access to CGMs in underserved regions, developing more affordable devices, and exploring innovative applications in diabetes management, such as integration with insulin pumps and artificial pancreas systems. Targeting specific diabetic populations with tailored solutions and expanding partnerships with healthcare providers will also generate new growth avenues.
Growth Accelerators in the Brazil Continuous Glucose Monitoring Market Industry
Long-term growth will be driven by further miniaturization and improved accuracy of CGM sensors, coupled with wider insurance coverage and increased government support. Strategic partnerships between CGM manufacturers and healthcare providers will play a critical role in expanding market reach and improving patient outcomes. The development of integrated diabetes management solutions and the adoption of telehealth platforms offer significant growth potential.
Key Players Shaping the Brazil Continuous Glucose Monitoring Market Market
- Abbott Diabetes Care
- Dexcom Inc
- Medtronic PLC
- Ascensia Diabetes Care
- GlySens
- Other
Notable Milestones in Brazil Continuous Glucose Monitoring Market Sector
- February 2023: Dexcom announced the launch of Dexcom G7 in South Africa, highlighting features like data sharing and customizable alerts, indicating a potential future launch in Brazil.
- October 2023: Partnership between Molex company Phillips-Medisize and GlucoModicum on a needle-free CGM signifies advancements in non-invasive technology, potentially impacting the Brazilian market in the future.
In-Depth Brazil Continuous Glucose Monitoring Market Market Outlook
The Brazilian CGM market holds significant long-term growth potential, fueled by the increasing prevalence of diabetes, technological advancements, and favorable government policies. Strategic partnerships, expansion into underserved regions, and the development of integrated diabetes management solutions will be crucial for capitalizing on this potential. The market is expected to witness a considerable increase in adoption rates and market penetration, leading to a robust and sustainable growth trajectory in the coming years.
Brazil Continuous Glucose Monitoring Market Segmentation
-
1. Component
- 1.1. Sensors
- 1.2. Durables
Brazil Continuous Glucose Monitoring Market Segmentation By Geography
- 1. Brazil

Brazil Continuous Glucose Monitoring Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 13.30% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rapidly Increasing Incidence and Prevalence of Diabetes; Technological Advancements in the Market
- 3.3. Market Restrains
- 3.3.1. Monopolized Supply Chain and High Cost of Devices
- 3.4. Market Trends
- 3.4.1. Rising Diabetes Prevalence in Brazil is anticipated to boost the market studied
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Brazil Continuous Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component
- 5.1.1. Sensors
- 5.1.2. Durables
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. Brazil
- 5.1. Market Analysis, Insights and Forecast - by Component
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Other
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Abbott Diabetes Care
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 GlySens
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Dexcom Inc
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medtronic PLC
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Ascensia Diabetes Care
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.1 Other
List of Figures
- Figure 1: Brazil Continuous Glucose Monitoring Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Brazil Continuous Glucose Monitoring Market Share (%) by Company 2024
List of Tables
- Table 1: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Component 2019 & 2032
- Table 4: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Component 2019 & 2032
- Table 5: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Component 2019 & 2032
- Table 10: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Component 2019 & 2032
- Table 11: Brazil Continuous Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: Brazil Continuous Glucose Monitoring Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Brazil Continuous Glucose Monitoring Market?
The projected CAGR is approximately 13.30%.
2. Which companies are prominent players in the Brazil Continuous Glucose Monitoring Market?
Key companies in the market include Other, Abbott Diabetes Care, GlySens, Dexcom Inc, Medtronic PLC, Ascensia Diabetes Care.
3. What are the main segments of the Brazil Continuous Glucose Monitoring Market?
The market segments include Component.
4. Can you provide details about the market size?
The market size is estimated to be USD 270.97 Million as of 2022.
5. What are some drivers contributing to market growth?
Rapidly Increasing Incidence and Prevalence of Diabetes; Technological Advancements in the Market.
6. What are the notable trends driving market growth?
Rising Diabetes Prevalence in Brazil is anticipated to boost the market studied.
7. Are there any restraints impacting market growth?
Monopolized Supply Chain and High Cost of Devices.
8. Can you provide examples of recent developments in the market?
October 2023: Molex company Phillips-Medisize and Finland-based medtech company GlucoModicum have partnered on an advanced non-invasive, needle-free continuous glucose monitor (CGM).
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Brazil Continuous Glucose Monitoring Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Brazil Continuous Glucose Monitoring Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Brazil Continuous Glucose Monitoring Market?
To stay informed about further developments, trends, and reports in the Brazil Continuous Glucose Monitoring Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence